TrialArthritis research & therapy2015

Low numbers of blood and salivary natural killer cells are associated with a better response to belimumab in primary Sjögren's syndrome: results of the BELISS study.

Raphaèle Seror et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.